Concepedia
9
Publications
589
Citations
H-Index
2017
Active since
Affiliations
Abbott Fund(Current)
Abbott (United States)
Abbott (United Kingdom)
University of Hong Kong
Queen Mary Hospital
Jeffrey Gersch is an author at Abbott Fund specializing in microbiology, medical laboratory science, and flavivirus.
Top concepts
MedicineVirologyFlavivirusMicrobiologyClinical Sciences
Publications per year
2017–2020
Pregenomic HBV RNA and Hepatitis B Core‐Related Antigen Predict Outcomes in Hepatitis B e Antigen–Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy
Ivana Carey, Jeffrey Gersch, Bo Wang et al. · Hepatology · 2019 · 166 citations
Hepatitis B Virus Serum DNA andRNA Levels in Nucleos(t)ide Analog‐Treated or Untreated Patients During Chronic and Acute Infection
Emily K. Butler, Jeffrey Gersch, Anne L. McNamara et al. · Hepatology · 2018 · 162 citations
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
Wai‐Kay Seto, K. S. H. Liu, Lung‐Yi Mak et al. · Gut · 2020 · 86 citations
HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy
Lung‐Yi Mak, Gavin Cloherty, Danny Ka‐Ho Wong et al. · Hepatology · 2020 · 84 citations
Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)
Seng Gee Lim, Wah Wah Phyo, Joanna Ling et al. · Alimentary Pharmacology & Therapeutics · 2020 · 29 citations · Full text
Rows per page
1–5 of 9